Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

NovoLog (Insulin Aspart [rDNA origin]) Injection
Company:  Novo Nordisk Pharmaceuticals, Inc.
Application No.:  20-986/S-003
Approval Date: 12/21/2001


Date created: July 25, 2002

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.